- Home
- PRZO vs PASG Comparison
PRZO vs PASG Comparison
Compare PRZO & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- PASG
- Stock Information
- Founded
- PRZO 2014
- PASG 2017
- Country
- PRZO Israel
- PASG United States
- Employees
- PRZO N/A
- PASG N/A
- Industry
- PRZO
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- PRZO
- PASG Health Care
- Exchange
- PRZO Nasdaq
- PASG Nasdaq
- Market Cap
- PRZO 25.1M
- PASG 27.6M
- IPO Year
- PRZO 2023
- PASG 2020
- Fundamental
- Price
- PRZO $1.32
- PASG $8.24
- Analyst Decision
- PRZO
- PASG Strong Buy
- Analyst Count
- PRZO 0
- PASG 4
- Target Price
- PRZO N/A
- PASG $34.50
- AVG Volume (30 Days)
- PRZO 522.3K
- PASG 41.6K
- Earning Date
- PRZO 08-28-2025
- PASG 11-10-2025
- Dividend Yield
- PRZO N/A
- PASG N/A
- EPS Growth
- PRZO N/A
- PASG N/A
- EPS
- PRZO N/A
- PASG N/A
- Revenue
- PRZO $1,007,440.00
- PASG N/A
- Revenue This Year
- PRZO N/A
- PASG N/A
- Revenue Next Year
- PRZO N/A
- PASG N/A
- P/E Ratio
- PRZO N/A
- PASG N/A
- Revenue Growth
- PRZO 80.42
- PASG N/A
- 52 Week Low
- PRZO $0.53
- PASG $5.12
- 52 Week High
- PRZO $3.16
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- PRZO 47.34
- PASG 53.96
- Support Level
- PRZO $1.28
- PASG $7.13
- Resistance Level
- PRZO $1.50
- PASG $9.24
- Average True Range (ATR)
- PRZO 0.10
- PASG 0.89
- MACD
- PRZO 0.02
- PASG 0.03
- Stochastic Oscillator
- PRZO 62.60
- PASG 57.09
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.